Genetics and genomics of psychiatric disease - PubMed
- ️Thu Jan 01 2015
Review
Genetics and genomics of psychiatric disease
Daniel H Geschwind et al. Science. 2015.
Abstract
Large-scale genomic investigations have just begun to illuminate the molecular genetic contributions to major psychiatric illnesses, ranging from small-effect-size common variants to larger-effect-size rare mutations. The findings provide causal anchors from which to understand their neurobiological basis. Although these studies represent enormous success, they highlight major challenges reflected in the heterogeneity and polygenicity of all of these conditions and the difficulty of connecting multiple levels of molecular, cellular, and circuit functions to complex human behavior. Nevertheless, these advances place us on the threshold of a new frontier in the pathophysiological understanding, diagnosis, and treatment of psychiatric disease.
Copyright © 2015, American Association for the Advancement of Science.
Figures

(A) Highest lifetime (point for ASD) prevalence in percentages. The discontinuous bar in phobias represents the range in different forms. (B) Heritability estimates; bars, standard error (SE). (C) SNP-based heritability estimates; bars, SE. (D) Number of genome-wide significant loci. The x axis is discontinuous because of the large difference of associated loci between disorders. (E) The number of associated structural variants (SVs) that either reach genome-wide significance or have been replicated with P ≤ 0.01 in another study. (F) The y axis shows associated GWAS loci (blue) and SVs (green) by the number of cases (x axis) in the largest study for that disorder. The number of cases in the largest study for GWAS (D) and SV studies (E) is reported next to each disorder. Abbreviations are as follows: ANX, any anxiety disorder; AAD, alcohol abuse disorder; MDD, major depressive disorder; PHO, = any phobia; CON, conduct disorders; PTSD, post traumatic stress disorder; EAT, eating disorders; TS, Tourette syndrome. The order of disorders and their color coding are maintained throughout the bar plots. See table S1 for underlying data and references amalgamated from many sources.

Plotted on the vertical axis are BPD, SCZ, MDD, and ASD (2). The horizontal colored lines mark the mean of the genetic correlation based on SNP sharing for each pair of illnesses, and the dotted vertical colored lines are the SEs of the estimates. Data are from Maier et al. (69).

Different study designs, such as trios, multiplex affected families, or case-control (shown at far left) identify different forms of genetic risk in cases (the arrow size indicates the relative effect size). By integrating these data with biological network data, one can assess in a genome-wide manner whether disease-associated risk variants are enriched in specific biological networks (46). Here, for illustration, we depict rare de novo variants associated with ASD, enriched in the yellow module. The function of this module of co-regulated genes can be further annotated using gene ontology, which implicates these large-effect ASD-associated variants in chromatin remodeling, transcriptional regulation, and neurogenesis. Networks can be subsequently mapped onto developmental time points, brain regions, circuits, or cells.

Clinical disorders (abbreviations are as in Fig. 1) and their overlap, represented by the big circles. The smaller dots within each circle represent contributing genetic or environmental risk factors. Once genetic risk is defined in population studies, it can be used to define factors underlying disease risk in individuals, identifying distinct (or overlapping) entities, two of which are represented by the elongated ovals at the bottom, grounded in causal mechanistic understanding. These subtypes should more clearly inform prognosis and treatment than do current categorical disease entities. The sizes of the dots within the circles represent the relative effect sizes of variants.
Similar articles
-
Large-scale genomics unveils the genetic architecture of psychiatric disorders.
Gratten J, Wray NR, Keller MC, Visscher PM. Gratten J, et al. Nat Neurosci. 2014 Jun;17(6):782-90. doi: 10.1038/nn.3708. Epub 2014 May 27. Nat Neurosci. 2014. PMID: 24866044 Free PMC article. Review.
-
The daunting polygenicity of mental illness: making a new map.
Hyman SE. Hyman SE. Philos Trans R Soc Lond B Biol Sci. 2018 Mar 19;373(1742):20170031. doi: 10.1098/rstb.2017.0031. Philos Trans R Soc Lond B Biol Sci. 2018. PMID: 29352030 Free PMC article. Review.
-
Imaging Genetics and Genomics in Psychiatry: A Critical Review of Progress and Potential.
Bogdan R, Salmeron BJ, Carey CE, Agrawal A, Calhoun VD, Garavan H, Hariri AR, Heinz A, Hill MN, Holmes A, Kalin NH, Goldman D. Bogdan R, et al. Biol Psychiatry. 2017 Aug 1;82(3):165-175. doi: 10.1016/j.biopsych.2016.12.030. Epub 2017 Jan 13. Biol Psychiatry. 2017. PMID: 28283186 Free PMC article. Review.
-
Genetics, neuroscience and psychiatric classification.
Robert JS, Plantikow T. Robert JS, et al. Psychopathology. 2005 Jul-Aug;38(4):215-8. doi: 10.1159/000086095. Psychopathology. 2005. PMID: 16145278
-
Reynolds T, Johnson EC, Huggett SB, Bubier JA, Palmer RHC, Agrawal A, Baker EJ, Chesler EJ. Reynolds T, et al. Neuropsychopharmacology. 2021 Jan;46(1):86-97. doi: 10.1038/s41386-020-00795-5. Epub 2020 Aug 13. Neuropsychopharmacology. 2021. PMID: 32791514 Free PMC article. Review.
Cited by
-
Advancing the understanding of autism disease mechanisms through genetics.
de la Torre-Ubieta L, Won H, Stein JL, Geschwind DH. de la Torre-Ubieta L, et al. Nat Med. 2016 Apr;22(4):345-61. doi: 10.1038/nm.4071. Nat Med. 2016. PMID: 27050589 Free PMC article. Review.
-
Inherited and De Novo Genetic Risk for Autism Impacts Shared Networks.
Ruzzo EK, Pérez-Cano L, Jung JY, Wang LK, Kashef-Haghighi D, Hartl C, Singh C, Xu J, Hoekstra JN, Leventhal O, Leppä VM, Gandal MJ, Paskov K, Stockham N, Polioudakis D, Lowe JK, Prober DA, Geschwind DH, Wall DP. Ruzzo EK, et al. Cell. 2019 Aug 8;178(4):850-866.e26. doi: 10.1016/j.cell.2019.07.015. Cell. 2019. PMID: 31398340 Free PMC article.
-
Gordon A, Forsingdal A, Klewe IV, Nielsen J, Didriksen M, Werge T, Geschwind DH. Gordon A, et al. Mol Psychiatry. 2021 May;26(5):1520-1534. doi: 10.1038/s41380-019-0576-0. Epub 2019 Nov 8. Mol Psychiatry. 2021. PMID: 31705054
-
Comprehensive functional genomic resource and integrative model for the human brain.
Wang D, Liu S, Warrell J, Won H, Shi X, Navarro FCP, Clarke D, Gu M, Emani P, Yang YT, Xu M, Gandal MJ, Lou S, Zhang J, Park JJ, Yan C, Rhie SK, Manakongtreecheep K, Zhou H, Nathan A, Peters M, Mattei E, Fitzgerald D, Brunetti T, Moore J, Jiang Y, Girdhar K, Hoffman GE, Kalayci S, Gümüş ZH, Crawford GE; PsychENCODE Consortium; Roussos P, Akbarian S, Jaffe AE, White KP, Weng Z, Sestan N, Geschwind DH, Knowles JA, Gerstein MB. Wang D, et al. Science. 2018 Dec 14;362(6420):eaat8464. doi: 10.1126/science.aat8464. Science. 2018. PMID: 30545857 Free PMC article.
-
Leffa DT, Castro Panzenhagen A, Luiz Rovaris D, Henrique Dotto Bau C, Rohde LA, Horacio Grevet E, Pires GN. Leffa DT, et al. BMJ Open Sci. 2018 Oct 19;2(1):e000001. doi: 10.1136/bmjos-2018-000001. eCollection 2018. BMJ Open Sci. 2018. PMID: 35047675 Free PMC article.
References
-
- Bettelheim B. The Empty Fortress: Infantile Autism and the Birth of the Self. New York: Free Press; 1972.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical